Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2055 (LINC02055) is a human long non-coding RNA gene located on chromosome 8q24.23 (chr8:135,859,369-137,092,183, forward strand), belonging to the lincRNA subclass of lncRNAs[1][3][5][7]. It is transcribed but not translated into a protein, and is presumed to regulate gene expression at transcriptional or epigenetic levels, based on the established roles of similar lincRNAs[2][6]. LINC02055 is also annotated as RP1130-1 and includes numerous splice variants, but its specific biological function, disease associations, drug interactions, or validated biomarker status are not currently described in public data[7]. There is no evidence at present that LINC02055 is a therapeutic or pharmacological target. Key references: - Gene annotation and aliases: [1][3][5][7] - lncRNA and lincRNA classification and functions: [2][6] No evidence for therapeutic targeting, disease linkage, safety issues, or specific mechanism for this gene could be found in current knowledgebases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2055 (LINC02055).